We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2891:TWSECTBC Financial Holding Company Ltd. Analysis

Data as of 2026-05-24 - not real-time

NT$64.40

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its short‑term moving average, suggesting immediate support. A bullish price direction is confirmed by the price staying within a narrow band between clear support and resistance levels. Volume has been on an upward trajectory, adding momentum to the price action. The relative strength index sits near the midpoint, indicating neither overbought nor oversold conditions. The MACD histogram is negative, hinting at a short‑term bearish pressure despite the overall uptrend. Low beta and modest 30‑day volatility point to a relatively stable price profile, while market sentiment is in an extreme‑greed phase.
Fundamentals reveal a price‑to‑earnings multiple that sits well above the sector average, raising concerns of overvaluation. The company enjoys strong profitability margins and a solid return on equity, underscoring operational efficiency. With no debt on the balance sheet and ample cash reserves, the balance sheet is exceptionally strong. An attractive dividend yield, supported by robust cash, enhances the income appeal. However, revenue growth has turned negative, which tempers the upside potential. Overall, the blend of defensive financial health and income generation makes the stock a candidate for value‑oriented investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term support
  • increasing volume
  • neutral RSI with slight MACD bearish pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • strong profitability and ROE
  • zero debt and ample cash
  • attractive dividend yield

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • solid financial health
  • sustainable dividend policy
  • value orientation despite high valuation

Key Metrics & Analysis

Financial Health

Revenue Growth-53.90%
Profit Margin14.59%
P/E Ratio25.3
ROE15.29%
ROA1.63%
P/B Ratio2.2
Industry P/E16.8

Technical Analysis

TrendBullish
RSI48.1
SupportNT$64.20
ResistanceNT$64.80
MA 20NT$64.55
MA 50NT$64.34
MA 200NT$63.75
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

GradeOvervalued
TypeValue
Dividend Yield3.51%

Risk Assessment

Beta-0.00
Volatility3.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.